Literature DB >> 10581980

Five cases of interferon-alpha-induced depression treated with antidepressant therapy.

O C Gleason1, W R Yates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10581980     DOI： 10.1016/S0033-3182(99)71190-4

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  14 in total

1.  Psychiatric care of the patient with hepatitis C: a review of the literature.

Authors:  Muhamad Aly Rifai; Ondria C Gleason; Douha Sabouni
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Major depressive disorder in hepatitis C: an open-label trial of escitalopram.

Authors:  Ondria C Gleason; William R Yates; Michelle A Philipsen
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Management of Hepatitis C in HIV-infected Patients.

Authors:  Benigno Rodriguez; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

4.  The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation.

Authors:  Richard Benoit Francoeur
Journal:  J Pain Symptom Manage       Date:  2005-02       Impact factor: 3.612

5.  Validation of the FACT-BRM with interferon-alpha treated melanoma patients.

Authors:  Amber G Paterson; Peter C Trask; Lynne I Wagner; Peg Esper; Bruce Redman
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

6.  A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.

Authors:  J M Loftis; J M Wall; E Linardatos; S Benvenga; P Hauser
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

7.  Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.

Authors:  Ondria C Gleason; John C Fucci; William R Yates; Michelle A Philipsen
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 8.  Neuropsychiatric side effects of interferon-alfa therapy.

Authors:  Arthur R Van Gool; Wim H J Kruit; Frederike K Engels; Gerrit Stoter; Marjolein Bannink; Alexander M M Eggermont
Journal:  Pharm World Sci       Date:  2003-02

9.  Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.

Authors:  Diana L Sylvestre; Jennifer M Loftis; Peter Hauser; Sander Genser; Helen Cesari; Nicolette Borek; Thomas F Kresina; Leonard Seeff; Henry Francis
Journal:  J Urban Health       Date:  2004-12       Impact factor: 3.671

10.  Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder.

Authors:  Peter Hauser; Benjamin J Morasco; Alex Linke; Dannell Bjornson; Samantha Ruimy; Annette Matthews; Aly Rifai; David W Indest; Jennifer M Loftis
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.